Patents by Inventor Emmanuel Meyer

Emmanuel Meyer has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • AZETIDIN-3-YLMETHANOL DERIVATIVES AS CCR6 RECEPTOR MODULATORS
    Publication number: 20230174514
    Abstract: The present invention relates to compounds of Formula (I), their synthesis and use as CCR6 receptor modulators for the treatment or prevention of various diseases, conditions or disorders.
    Type: Application
    Filed: April 30, 2021
    Publication date: June 8, 2023
    Inventors: Oliver ALLEMANN, Eva CAROFF, Alexia CHAVANTON-ARPEL, Andrew CROXFORD, Francis HUBLER, Loïc JACOB, Emmanuel MEYER, Sylvia RICHARD-BILDSTEIN
  • 1-(piperazin-1-yl)-2-([1,2,4]triazol-1-yl)-ethanone derivatives
    Patent number: 10259807
    Abstract: The invention relates to compounds of Formula (I) wherein X, Y, R1, R2, R3, R4 and R5 are as described in the description; to pharmaceutically acceptable salts thereof, and to the use of such compounds as medicaments, especially as modulators of the CXCR3 receptor.
    Type: Grant
    Filed: July 21, 2014
    Date of Patent: April 16, 2019
    Assignee: IDORSIA PHARMACEUTICALS LTD.
    Inventors: Eva Caroff, Emmanuel Meyer
  • Hydroxyalkyl-piperazine derivatives as CXCR3 receptor modulators
    Patent number: 10053457
    Abstract: The invention relates to compounds of Formula (I) wherein n, X, R1 and R2 are as described in the description; to pharmaceutically acceptable salts thereof, and to the use of such compounds as medicaments, especially as modulators of the CXCR3 receptor.
    Type: Grant
    Filed: January 14, 2016
    Date of Patent: August 21, 2018
    Assignee: IDORSIA PHARMACEUTICALS LTD.
    Inventors: Eva Caroff, Emmanuel Meyer
  • (R)-2-methyl-piperazine derivatives as CXCR3 receptor modulators
    Patent number: 10047080
    Abstract: The invention relates to compounds of Formula (I) wherein R1 and R2 are as described in the description; to pharmaceutically acceptable salts thereof, and to the use of such compounds as medicaments, especially as modulators of the CXCR3 receptor.
    Type: Grant
    Filed: January 14, 2016
    Date of Patent: August 14, 2018
    Assignee: IDORSIA PHARMACEUTICALS LTD.
    Inventors: Eva Caroff, Emmanuel Meyer
  • 8-(piperazin-1-yl)-1,2,3,4-tetrahydro-isoquinoline derivatives
    Patent number: 9951063
    Abstract: The invention relates to compounds of Formula (I) wherein R1, R2, R3, R4 and R5 are as described in the description; to pharmaceutically acceptable salts thereof, and to the use of such compounds as medicaments, especially as modulators of the CXCR3 receptor.
    Type: Grant
    Filed: March 23, 2015
    Date of Patent: April 24, 2018
    Assignee: IDORSIA PHARMACEUTICALS LTD
    Inventors: Eva Caroff, Rémy Castro, Emmanuel Meyer, Thierry Kimmerlin
  • HYDROXYALKYL-PIPERAZINE DERIVATIVES AS CXCR3 RECEPTOR MODULATORS
    Publication number: 20180009799
    Abstract: The invention relates to compounds of Formula (I) wherein n, X, R1 and R2 are as described in the description; to pharmaceutically acceptable salts thereof, and to the use of such compounds as medicaments, especially as modulators of the CXCR3 receptor.
    Type: Application
    Filed: January 14, 2016
    Publication date: January 11, 2018
    Inventors: Eva CAROFF, Emmanuel MEYER
  • (R)-2-Methyl-piperazine Derivatives as CXCR3 Receptor Modulators
    Publication number: 20180009800
    Abstract: The invention relates to compounds of Formula (I) wherein R1 and R2 are as described in the description; to pharmaceutically acceptable salts thereof, and to the use of such compounds as medicaments, especially as modulators of the CXCR3 receptor.
    Type: Application
    Filed: January 14, 2016
    Publication date: January 11, 2018
    Inventors: Eva CAROFF, Emmanuel MEYER
  • 8-(PIPERAZIN-1-YL)-1,2,3,4-TETRAHYDRO-ISOQUINOLINE DERIVATIVES
    Publication number: 20170107214
    Abstract: The invention relates to compounds of Formula (I) wherein R1, R2, R3, R4 and R5 are as described in the description; to pharmaceutically acceptable salts thereof, and to the use of such compounds as medicaments, especially as modulators of the CXCR3 receptor.
    Type: Application
    Filed: March 23, 2015
    Publication date: April 20, 2017
    Applicant: ACTELION PHARMACEUTICALS LTD
    Inventors: Eva CAROFF, Rémy CASTRO, Emmanuel MEYER, Thierry KIMMERLIN
  • 1-(PIPERAZIN-1-YL)-2-([1,2,4]TRIAZOL-1-YL)-ETHANONE DERIVATIVES
    Publication number: 20160176862
    Abstract: The invention relates to compounds of Formula (I) wherein X, Y, R1, R2, R3, R4 and R5 are as described in the description; to pharmaceutically acceptable salts thereof, and to the use of such compounds as medicaments, especially as modulators of the CXCR3 receptor.
    Type: Application
    Filed: July 21, 2014
    Publication date: June 23, 2016
    Inventors: Eva CAROFF, Emmanuel MEYER
  • 4-(benzoimidazol-2-yl)-thiazole compounds and related aza derivatives
    Patent number: 9266876
    Abstract: The invention relates to compounds of Formula (I), wherein ring A, X, (R1)n, R2, R3, R4, R4?, R5, n, and p are as described in the description; to pharmaceutically acceptable salts thereof, and to the use of such compounds as medicaments, especially as modulators of the CXCR3 receptor.
    Type: Grant
    Filed: February 1, 2013
    Date of Patent: February 23, 2016
    Assignee: Actelion Pharmaceuticals Ltd.
    Inventors: Eva Caroff, Marcel Keller, Thierry Kimmerlin, Emmanuel Meyer
  • 4-(Benzoimidazol-2-yl)-thiazole Compounds and Related Aza Derivatives
    Publication number: 20140371204
    Abstract: The invention relates to compounds of Formula (I) wherein ring A, X, (R1)n, R2, R3, R4, R4?, R5, n, and p are as described in the description; to pharmaceutically acceptable salts thereof, and to the use of such compounds as medicaments, especially as modulators of the CXCR3 receptor.
    Type: Application
    Filed: February 1, 2013
    Publication date: December 18, 2014
    Inventors: Eva Caroff, Marcel Keller, Thierry Kimmerlin, Emmanuel Meyer
  • Thiazole derivatives and their use as P2Y12 receptor antagonists
    Patent number: 8664203
    Abstract: The present invention relates to thiazole derivatives of formula I and their use as P2Y12 receptor antagonists in the treatment and/or prevention of peripheral vascular, of visceral-, hepatic- and renal-vascular, of cardiovascular and of cerebrovascular diseases or conditions associated with platelet aggregation, including thrombosis in humans and other mammals.
    Type: Grant
    Filed: April 21, 2010
    Date of Patent: March 4, 2014
    Assignee: Actelion Pharmaceuticals Ltd.
    Inventors: Eva Caroff, Kurt Hilpert, Francis Hubler, David Lehmann, Emmanuel Meyer, Dorte Renneberg
  • THIAZOLE DERIVATIVES AND THEIR USE AS P2Y12 RECEPTOR ANTAGONISTS
    Publication number: 20130281406
    Abstract: The present invention relates to thiazole derivatives of Formula (I) and their use as P2Y12 receptor antagonists in the treatment and/or prevention of peripheral vascular, of visceral-, hepatic- and renal-vascular, of cardiovascular and of cerebrovascular diseases or conditions associated with platelet aggregation, including thrombosis in humans and other mammals.
    Type: Application
    Filed: April 21, 2010
    Publication date: October 24, 2013
    Applicant: Actelion Pharmaceuticals Ltd.
    Inventors: Eva CAROFF, Kurt HILPERT, Francis HUBLER, David LEHMANN, Emmanuel MEYER, Dorte RENNEBERG
  • Phosphonic acid derivates and their use as P2Yreceptor antagonists
    Patent number: 8518912
    Abstract: The invention relates to 2-phenyl-pyrimidine derivatives containing a phosphonic acid motif and their use as P2Y12 receptor antagonists in the treatment and/or prevention of peripheral vascular, of visceral-, hepatic- and renal-vascular, of cardiovascular and of cerebrovascular diseases or conditions associated with platelet aggregation, including thrombosis in humans and other mammals. (I).
    Type: Grant
    Filed: November 28, 2008
    Date of Patent: August 27, 2013
    Assignee: Actelion Pharmaceuticals Ltd.
    Inventors: Eva Caroff, Kurt Hilpert, Francis Hubler, Emmanuel Meyer, Dorte Renneberg
  • 2-phenyl-4-cyclopropyl-pyrimidine derivatives
    Patent number: 8466156
    Abstract: The present invention relates to 2-phenyl-4-cyclopropyl-pyrimidine derivatives and their use as P2Y12 receptor antagonists in the treatment and/or prevention of peripheral vascular, of visceral-, hepatic- and renal-vascular, of cardiovascular and of cerebrovascular diseases or conditions associated with platelet aggregation, including thrombosis in humans and other mammals.
    Type: Grant
    Filed: April 9, 2009
    Date of Patent: June 18, 2013
    Assignee: Actelion Pharmaceuticals Ltd.
    Inventors: Eva Caroff, Emmanuel Meyer
  • System and method for non-thermal plasma treatment of foodstuffs
    Patent number: 8372460
    Abstract: A method for sanitation and preservation of foodstuffs includes the following steps. A container containing a foodstuff is provided. A non-thermal plasma is introduced to an interior of the container. The container is sealed.
    Type: Grant
    Filed: December 31, 2009
    Date of Patent: February 12, 2013
    Assignees: L'Air Liquide Societe Anonyme pour l'Etude et l'Exploitation des Procedes Georges Claude, American Air Liquide, Inc.
    Inventors: Pierre-Emmanuel Meyers, Jean-Christophe Rostaing, Rajat Agrawal
  • 6-(3-aza-bicyclo[3.1.0]hex-3-yl)-2-phenyl-pyrimidines
    Patent number: 8288385
    Abstract: The present invention relates to 6-(3-aza-bicyclo[3.1.0]hex-3-yl)-2-phenyl-pyrimidine derivatives and their use as P2Y12 receptor antagonists in the treatment and/or prevention of peripheral vascular, of visceral-, hepatic- and renal-vascular, of cardiovascular and of cerebrovascular diseases or conditions associated with platelet aggregation, including thrombosis in humans and other mammals.
    Type: Grant
    Filed: April 7, 2010
    Date of Patent: October 16, 2012
    Assignee: Actelion Pharmaceuticals Ltd.
    Inventors: Eva Caroff, Kurt Hilpert, Francis Hubler, Emmanuel Meyer, Dorte Renneberg
  • THIAZOLE DERIVATIVES AND THEIR USE AS P2Y12 RECEPTOR ANTAGONISTS
    Publication number: 20120053149
    Abstract: The present invention relates to thiazole derivatives of formula I and their use as P2Y12 receptor antagonists in the treatment and/or prevention of peripheral vascular, of visceral-, hepatic- and renal-vascular, of cardiovascular and of cerebrovascular diseases or conditions associated with platelet aggregation, including thrombosis in humans and other mammals.
    Type: Application
    Filed: April 21, 2010
    Publication date: March 1, 2012
    Inventors: Eva Caroff, Kurt Hilpert, Francis Hubler, David Lehmann, Emmanuel Meyer, Dorte Renneberg
  • 6-(3-AZA-BICYCLO[3.1.0]HEX-3-YL)-2-PHENYL-PYRIMIDINES
    Publication number: 20120028989
    Abstract: The present invention relates to 6-(3-aza-bicyclo[3.1.0]hex-3-yl)-2-phenyl-pyrimidine derivatives and their use as P2Y12 receptor antagonists in the treatment and/or prevention of peripheral vascular, of visceral-, hepatic- and renal-vascular, of cardiovascular and of cerebrovascular diseases or conditions associated with platelet aggregation, including thrombosis in humans and other mammals.
    Type: Application
    Filed: April 7, 2010
    Publication date: February 2, 2012
    Inventors: Eva Caroff, Kurt Hilpert, Francis Hubler, Emmanuel Meyer, Dorte Renneberg
  • 2-aminocarbonyl-pyridine derivatives
    Patent number: 8093250
    Abstract: The present invention relates to 2-aminocarbonyl-pyridine derivatives of Formula (I) and their use as P2Y12 receptor antagonists in the treatment and/or prevention of peripheral vascular, of visceral-, hepatic- and renal-vascular, of cardiovascular and of cerebrovascular diseases or conditions associated with platelet aggregation, including thrombosis.
    Type: Grant
    Filed: October 12, 2007
    Date of Patent: January 10, 2012
    Assignee: Actelion Pharmaceuticals Ltd.
    Inventors: Eva Caroff, Kurt Hilpert, Emmanuel Meyers